Convalescent plasma

Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.

Dr. Doug Brust of Lee Health gives an update on the use of convalescent plasma with COVID-19 patients and also informs on a new monoclonal antibody treatment from Eli Lilly.

Federal, Florida and local law enforcement officials who have recovered from COVID-19 are partnering with OneBlood to raise awareness about plasma…

University of Florida Health announced Tuesday it enrolled two patients in a national clinical trial about convalescent blood plasma and whether it can…

NPR's Ari Shapiro talks with Health and Human Services Secretary Alex Azar about the Food and Drug Administration allowing the use of convalescent plasma to treat COVID-19.

President Trump announced on Sunday that the FDA granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on "promising" results.

The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.

The National Institutes of Health has asked the Food and Drug Administration to delay allowing the use of convalescent plasma to treat COVID-19 because the proof of its effectiveness is weak.

Gov. Ron DeSantis put out a call Monday for people who have had COVID-19 to donate blood, as the state topped 5,000 deaths of Florida residents due to the…

As many firms and academic researchers vie for blood donations from survivors in hopes of isolating components for new treatments, one project is turning for help from 10,000 Orthodox Jewish women.